Ticker Details
Immunocore Holdings
IPO Date:	February 5, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.44B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.03 | 2.53%
Avg Daily Range (30 D):	$0.66 | 2.23%
Avg Daily Range (90 D):	$0.59 | 1.89%

Institutional Daily Volume
Avg Daily Volume:	.27M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.38M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	2,008
Avg Institutional Trade:	$1.72M
Avg Institutional Trade (30 D):	$1.4M
Avg Institutional Trade (90 D):	$1.31M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$1.02M
Avg Closing Trade (90 D):	$.91M
Avg Closing Volume:	34.69K

News

May 31, 2026 @ 12:00 PM Immunocore presents updated Phase 1 data of brenet... Source: Immunocore Holdings Plc

May 6, 2026 @ 11:00 AM Immunocore reports first quarter financial results... Source: Immunocore Holdings Plc

Apr 19, 2026 @ 10:00 PM KIMMTRAK doubles the likelihood of being alive at ... Source: Immunocore Holdings Plc

Mar 3, 2026 @ 12:00 PM Immunocore to present at upcoming investor confere... Source: Na

Feb 18, 2026 @ 12:00 PM Immunocore to report fourth quarter and full year ... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.54	$.26	$-.6
Diluted EPS	$-.55	$.25	$-.6
Revenue	$412.81M	$106.68M	$104.48M
Gross Profit	$408.12M	$106.24M	$101.78M
Net Income / Loss	$-27.57M	$12.97M	$-30.06M
Operating Income / Loss	$-34.46M	$7.28M	$-19.69M
Cost of Revenue	$4.69M	$.43M	$2.7M
Net Cash Flow	$-24.17M	$-15.03M	$-30.7M
PE Ratio